Streetbeat News

Stock Prices

ABBV

A significant amount of unusual options activity has been detected for AbbVie (NYSE:ABBV), with a bearish stance being taken by a whale investor. Of the 16 strange trades detected, 43% were bullish and 56% were bearish. The trades included 2 puts amounting to $59,185 and 14 calls amounting to $680,506. The targeted price range for AbbVie over the last 3 months has been between $70.0 and $190.0. The current price of ABBV is up 1.78% at $151.92, with RSI indicators suggesting it may be approaching overbought.

Portfolio Pulse from Benzinga Insights

September 13, 2023 | 6:15 pm

JBHT

J.B. Hunt Transport Services' shares are trading higher after the company's presentation at the Morgan Stanley 11th Annual Laguna Conference.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 6:11 pm

DIS

GBTC

This week's investment news highlights include the potential end of disinflation due to rising oil prices, the falling Japanese yen, the possibility of a Bitcoin ETF following a lawsuit win by Grayscale, Disney's lack of shareholder value creation over the past decade, and mixed data on unemployment. The news suggests potential impacts on the stocks of Grayscale Bitcoin Trust (GBTC) and Disney (DIS).

Portfolio Pulse from Gary Brode

September 13, 2023 | 6:09 pm

AVTX

EIGR

HRT

RCKT

REVG

Several stocks experienced significant price movements in Wednesday's mid-day session. Eiger BioPharmaceuticals shares dropped by 52.5% after the company decided to discontinue a Phase 3 study. Avalo Therapeutics shares surged by 68% after receiving a notice from Nasdaq. Rocket Pharmaceuticals rose by 31.8% after reaching alignment with the FDA on a global Phase 2 trial. HireRight Holdings climbed by 14.8% after planning an additional $25 million share repurchase program. REV Group surged by 9.2% after reporting better-than-expected Q3 results and raising FY23 net sales guidance.

Portfolio Pulse from Lisa Levin

September 13, 2023 | 6:07 pm

MRNA

During the Investor Day Conference, a Moderna executive stated that the total respiratory vaccine market could reach up to $30 billion. This suggests a significant potential for growth in the vaccine market.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 6:05 pm

HOLO

MicroCloud Hologram's shares are trading lower on unusually high volume, with no company-specific news to justify the price action.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 6:04 pm

CASY

Raymond James analyst Bobby Griffin reiterated a Market Perform rating on Casey's General Stores Inc (NASDAQ:CASY) after its 1Q FY24 earnings exceeded expectations. The company's unique business model, focusing on small towns, large food business, and growing customer loyalty, sets it apart from other industry participants. The analyst anticipates the addition of at least 150 stores in FY24, up from the previous outlook of 110 stores. CASY shares are trading higher by 3.04% at $274.20.

Portfolio Pulse from Shivani Kumaresan

September 13, 2023 | 6:03 pm

HRT

HireRight has announced an additional $25 million share repurchase program, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 6:03 pm

IOVA

Analysts have provided bullish ratings for Iovance Biotherapeutics (NASDAQ:IOVA) within the last quarter, with an average price target of $28.3 versus the current price of $5.5. This average has increased by 1.07% from the previous average price target of $28.00.

Portfolio Pulse from Benzinga Insights

September 13, 2023 | 6:00 pm

ADBE

Adobe's shares are trading higher in anticipation of the company's upcoming earnings report. The company has also announced new product releases.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 6:00 pm